NCT07574255

Brief Summary

The goal of this observational study is to establish the three-dimensional construct of lung lesion via ultrasound in patients with peripheral lung lesions or any superficial lesion in thoracic fields. The primary question our study aims to answer is: Whether the 3D ultrasound morphology can reflect lung disease entities? Whether the 3D volumetric follow-up protocol can be standardised to reflect lung disease status?

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
58mo left

Started May 2026

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 3, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 7, 2026

Completed
23 days until next milestone

Study Start

First participant enrolled

May 30, 2026

Expected
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2031

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2031

Last Updated

May 7, 2026

Status Verified

May 1, 2026

Enrollment Period

4.8 years

First QC Date

May 3, 2026

Last Update Submit

May 3, 2026

Conditions

Keywords

lung ultrasoundthree-dimensional ultrasoundperipheral lung lesions

Outcome Measures

Primary Outcomes (1)

  • volume of measured lesion

    Standard volume will be defined by computed tomography measurement, and the ultrasound 3D-volmetric result would be compared

    from enrollment, every 6 weeks until 24th week

Study Arms (1)

ultrasound work-up

participants with peripheral lesions, not confined to lung, referred for ultrasound workup

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants with peripheral lung lesions or with lesions located at superficial thoracic field will be recruited from referral cases for ultrasound workup

You may qualify if:

  • Participants suspect with lung lesions referred for ultrasound workup

You may not qualify if:

  • Participants aged \< 18 years
  • Participants refusal
  • Participants with implanted metal in scanning area interfering data collection
  • Participants who cannot perform breath holding for at least 1 second

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, Taiwan

Location

MeSH Terms

Conditions

Lung NeoplasmsDisease

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • YEN-LIN CHEN, Doctor of Medicine

    National Taiwan University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

YEN-LIN CHEN, Doctor of Medicine

CONTACT

YAO-WEN KUO, Ph.D

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 3, 2026

First Posted

May 7, 2026

Study Start (Estimated)

May 30, 2026

Primary Completion (Estimated)

February 28, 2031

Study Completion (Estimated)

February 28, 2031

Last Updated

May 7, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Individual data may contain images with unremovable personal information, which may violate the Personal Data Protection Act.

Locations